BioCentury
ARTICLE | Top Story

Abgenix deal with Immunex

July 26, 2000 7:00 AM UTC

The companies will jointly develop and commercialize ABGX's ABX-EGF, a human antibody against the EGF receptor, which is in Phase I testing to treat tumors. ABGX will receive an upfront license paymen...